Pharmaceutical Stocks Including Kukje Pharmaceutical Surge on Suspicion of Plague Leak in Russia
Read with caution - this story is only being covered by one news source that has a ‘low factuality’ rating, which means the outlet has a history of poor reporting practices. Learn more about factuality ratings here.4 Articles
4 Articles
Photo: Belova59 (Pixabay) Journalist Kim Iversen draws a disturbing conclusion in a new video: the timing of possible plague cases in Russia is anything but coincidental. What is known so far In the Russian region of Irkutsk …
On the 7th, the pharmaceutical and biotech industry was significantly affected by the suspected plague (Black Death) leak in Russia, leading to continued buying interest across diagnostic companies such as Humasis (205470), GC MS (142280), and GeneMatrix (109820). However, caution is required in investment, as it is known that no domestic diagnostic company currently possesses a commercially available plague diagnostic kit. On the other hand, Pe…
As a researcher at the Russian Siberian Plague Research Institute died from symptoms of pneumonia of unknown cause and the possibility of a plague pathogen leak was raised, pharmaceutical, biotech, and diagnostic-related stocks in the domestic stock market are showing simultaneous strength. According to the Korea Exchange on the 7th, as of 10:08 AM, Kukje Pharmaceutical was trading at 4,430 won, having risen to the daily limit (29.91%) compared…
A plague research institute in Siberia, Russia, experienced a pathogen leak, resulting in the death of one researcher and the hospitalization of 200 people. Additionally, some netizens discovered that approximately one month prior, Chinese official media reported that from August 24th to 27th, China and Russia held a joint cross-border infectious disease emergency drill in Fuyuan, Heilongjiang Province, one scenario of which involved the handlin…
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
